News

  • Evaluation results from FLU A/B + RSV assay

    26.9.2019

    If you somehow happened to miss the chance to review poster P111 from the latest ESCV event, please take a look at the attached pdf. There you can find some excellent evaluation results concerning our FLU A/B + RSV assay performed with GenomEra.

    https://www.abacusdiagnostica.com/wp-content/uploads/2019/09/Choquet_ESCV_2019.pdf

  • Great FLU A/B + RSV results at ESCV 2019!

    12.9.2019

    ESCV conference is taking place in Copenhagen. Dr. Pichon from CHU Poitiers, France is presenting first and excellent results from GenomEra Flu A/B + RSV evaluations, which they did in last winter. Go to check poster P111. Should you wish to select GenomEra system for next influenza season, please contact info@abacusdiagnostica.com to order a demo.

  • New publication of the upcoming direct GenomEra GBS assay for intrapartum screening is available

    16.5.2019

    Results shows equal sensitivity to culture and article highlights the usability of GenomEra.

    From the conclusions: “GenomEra GBS PCR assay has potential as an easy and rapid on-site test for intrapartum detection of vaginal carriage of GBS at a maternity ward to identify women in labor who should receive intrapartum antibiotic prophylaxis.”

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215314

  • GenomEra Flu A/B + RSV CE IVD approved and available!

    9.4.2019

    Abacus Diagnostica´s GenomEra Flu A/B + RSV is now CE IVD approved and available! To discuss more about our new product, come and meet us at ECCMID 2019 in Amsterdam, booth 1.148!

    Results:

    Analyte                                 PPA (i.e. sensitivity)                        NPA (i.e. specificity)        Accuracy

    Flu A (n=1256)                   97.1%                                                    99.4%                                    98.6%

    Flu B (n=1256)                   100%                                                     100%                                     100%

    RSV (n=701)                        98%                                                        99.8%                                    98.7%

    Overall accuracy:  99.3%

  • Abacus Diagnostica is exhibiting at ECCMID 2019

    25.3.2019

    Abacus Diagnostica is exhibiting at ECCMID 2019. Contact us to book your meeting with the team to hear the latest news! See you in few weeks at booth #1.148!

    https://www.eccmid.org/

  • Abacus Diagnostica at Labquality Days 2019

    14.1.2019

    Come and meet us at Labquality Days 2019 in Helsinki Conference Centre during 7-8th of February! We will be exhibiting at stand S1 and happy to answer questions concerning our upcoming FLU A/B + RSV.

  • Announcement of new distributors

    29.11.2018

    We are proud to announce our new distributors as follows:

    • Intuitive Technology Ltd covering Hong Kong and Macau,
    • Medicon Hellas S.A. covering Greece
    • Triolab Baltic OÜ covering Estonia, Lithuania and Latvia
    • HVD Life Sciences covering Israel, Lebanon, Egypt, Jordan, Oman and United Arab Emirates
    • Bergman Diagnostika A/S covering Norway

    Please visit www.abacusdiagnostica.com/distributors to view the the complete list.

  • Abacus Diagnostica at Medica 2018

    5.11.2018

                    Meet us at Medica 2018 in Düsseldorf 12-15.11.2018. Please contact info@abacusdiagnostica.com to schedule a meeting.

  • Influenza A/B & RSV

    15.10.2018

     

    We are completing our new test Influenza A/B & RSV and we will start evaluations during November 2018. If you are interested, please contact us.

  • Abacus Diagnostica at ESCV 2018

    13.9.2018

    Our CEO Erno Sundberg will be present at the ESCV 2018 event. He will be available during the whole time. Come and collect the latest updates on our influenza A/B & RSV tests.